newsfilter
← Latest News
GlobeNewswire·

GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference

Preclinical Data for GEO-CM02 Demonstrates Single-Dose ProtectionAgainst Multiple SARS-CoV-2 Variants ATLANTA, GA, Sept. 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a